The copy number variation landscape of congenital anomalies of the kidney and urinary tractMiguel Verbitsky, Robert Pawluch, Qingxue Liu et al.|Nature Genetics|2018Cited by 240
Efficacy and Safety of Rituximab Second-Line Therapy for Membranous Nephropathy: A Prospective, Matched-Cohort StudyPaolo Cravedi, Piero Ruggenenti, Maria Chiara Sghirlanzoni et al.|American Journal of Nephrology|2011Cited by 71
Strong protective effect of the APOL1 p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney diseaseYask Gupta, Daniel L. Bivona, David J. Friedman et al.|Nature Communications|2023Cited by 68
Multi-population genome-wide association study implicates immune and non-immune factors in pediatric steroid-sensitive nephrotic syndromeAlexandra Barry, Claire Dossier, Michelle T. McNulty et al.|Nature Communications|2023Cited by 50